v3.26.3
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Preferred Stock
Series A Convertible Preferred Stock
Preferred Stock
Series B Convertible Preferred Stock
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Income
Accumulated Deficit
Beginning Balance at Dec. 31, 2024 $ 710,405   $ 3 $ 13 $ 3,095,987 $ (1,046) $ (2,384,552)
Beginning Balance (in Shares) at Dec. 31, 2024   194 2,842,158 305,252,194      
Stock-based compensation expense 49,206       49,206    
Common stock issued upon purchase of employee stock purchase plan 671       671    
Common stock issued upon purchase of employee stock purchase plan (in shares)       357,163      
Vesting of restricted shares issued for services (in shares)       4,651,490      
Tax payments related to shares retired for vested restricted stock units (6,614)       (6,614)    
Tax payments related to shares retired for vested restricted stock units (in shares)       (1,856,719)      
Common stock issued upon exercise of stock options 15       15    
Common stock issued upon exercise of stock options (in shares)       2,586      
Common stock sold in public and/or at the market offering, net of offering costs 250,529     $ 3 250,526    
Common stock sold in public and/or at the market offering, net of offering costs (in shares)       76,145,523      
Common stock issued from preferred stock conversion     $ (1)   1    
Common stock issued from preferred stock conversion (in Shares)     (909,491) 909,491      
Unrealized income (loss) on investments (40)         (40)  
Foreign currency cumulative translation adjustment 17,189         17,189  
Net Loss (319,074)           (319,074)
Ending Balance at Sep. 30, 2025 702,287   $ 2 $ 16 3,389,792 16,103 (2,703,626)
Ending Balance (in Shares) at Sep. 30, 2025   194 1,932,667 385,461,728      
Beginning Balance at Jun. 30, 2025 698,488   $ 2 $ 14 3,289,986 20,859 (2,612,373)
Beginning Balance (in Shares) at Jun. 30, 2025   194 1,932,667 341,919,364      
Stock-based compensation expense 11,751       11,751    
Common stock issued upon purchase of employee stock purchase plan 3       3    
Common stock issued upon purchase of employee stock purchase plan (in shares)       1,455      
Vesting of restricted shares issued for services (in shares)       509,742      
Tax payments related to shares retired for vested restricted stock units (464)       (464)    
Tax payments related to shares retired for vested restricted stock units (in shares)       (211,322)      
Common stock sold in public and/or at the market offering, net of offering costs 88,518     $ 2 88,516    
Common stock sold in public and/or at the market offering, net of offering costs (in shares)       43,242,489      
Unrealized income (loss) on investments 100         100  
Foreign currency cumulative translation adjustment (4,856)         (4,856)  
Net Loss (91,253)           (91,253)
Ending Balance at Sep. 30, 2025 702,287   $ 2 $ 16 3,389,792 16,103 (2,703,626)
Ending Balance (in Shares) at Sep. 30, 2025   194 1,932,667 385,461,728      
Beginning Balance at Dec. 31, 2025 698,583   $ 2 $ 17 3,457,654 16,440 (2,775,530)
Beginning Balance (in Shares) at Dec. 31, 2025   194 1,932,667 411,938,061      
Stock-based compensation expense 35,391       35,391    
Common stock issued upon purchase of employee stock purchase plan 861       861    
Common stock issued upon purchase of employee stock purchase plan (in shares)       448,277      
Vesting of restricted shares issued for services (in shares)       4,000,228      
Tax payments related to shares retired for vested restricted stock units (7,764)       (7,764)    
Tax payments related to shares retired for vested restricted stock units (in shares)       (1,538,852)      
Common stock issued upon exercise of stock options $ 831       831    
Common stock issued upon exercise of stock options (in shares) 172,413     109,441      
Common stock sold in public and/or at the market offering, net of offering costs $ 235,978     $ 2 235,976    
Common stock sold in public and/or at the market offering, net of offering costs (in shares)       47,586,231      
Unrealized income (loss) on investments (251)         (251)  
Foreign currency cumulative translation adjustment (2,336)         (2,336)  
Net Loss (148,631)           (148,631)
Ending Balance at Sep. 30, 2026 812,662   $ 2 $ 19 3,722,949 13,853 (2,924,161)
Ending Balance (in Shares) at Sep. 30, 2026   194 1,932,667 462,543,386      
Beginning Balance at Jun. 30, 2026 736,045   $ 2 $ 19 3,624,836 13,078 (2,901,890)
Beginning Balance (in Shares) at Jun. 30, 2026   194 1,932,667 452,971,016      
Stock-based compensation expense 11,830       11,830    
Vesting of restricted shares issued for services (in shares)       1,095,918      
Tax payments related to shares retired for vested restricted stock units (2,419)       (2,419)    
Tax payments related to shares retired for vested restricted stock units (in shares)       (291,011)      
Common stock issued upon exercise of stock options 805       805    
Common stock issued upon exercise of stock options (in shares)       100,809      
Common stock sold in public and/or at the market offering, net of offering costs 87,897       87,897    
Common stock sold in public and/or at the market offering, net of offering costs (in shares)       8,666,654      
Unrealized income (loss) on investments (114)         (114)  
Foreign currency cumulative translation adjustment 889         889  
Net Loss (22,271)           (22,271)
Ending Balance at Sep. 30, 2026 $ 812,662   $ 2 $ 19 $ 3,722,949 $ 13,853 $ (2,924,161)
Ending Balance (in Shares) at Sep. 30, 2026   194 1,932,667 462,543,386